Frédéric Maloisel

6.9k citations
76 papers · 3.0k · h-index 30

Impact in

  • Hematology top 0.5%
    • Multiple Myeloma Research and Treatments
    • Chronic Myeloid Leukemia Treatments
    • Acute Myeloid Leukemia Research
  • Genetics top 1%
    • Chronic Lymphocytic Leukemia Research
    • Blood disorders and treatments

Papers in

    • Chronic Myeloid Leukemia Treatments 20
    • Multiple Myeloma Research and Treatments 7
    • Platelet Disorders and Treatments 6
    • Chronic Lymphocytic Leukemia Research 22
    • Blood disorders and treatments 15

Frédéric Maloisel

72 papers receiving 2.8k citations

Peers

Frédéric Maloisel
Comparison fields: 5 of 87
  • Hematology 1.5k
  • Genetics 562
  • Oncology 759
  • Pathology and Forensic Medicine 449
  • Rheumatology 366
Replace Martin Zimmermann with:
Martin Zimmermann Germany
Vikram Mathews India
Albert Altés Spain
H. L. Haak Netherlands
Philippe Casassus France
David Lawrence United States
K Sawada Japan
Enrico Pogliani Italy
Brendan M. Weiss United States
Wilfried Schroyens Belgium
Frédéric Maloisel relative to Martin Zimmermann Germany Martin Zimmermann's profile →
Citations per field
00.5×3.5×
Martin Zimmermann · 1×
Citations per year

Countries citing papers authored by Frédéric Maloisel

Since Specialization
Citations

This map shows the geographic impact of Frédéric Maloisel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Maloisel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Maloisel more than expected).

Fields of papers citing papers by Frédéric Maloisel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Maloisel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Maloisel. The network helps show where Frédéric Maloisel may publish in the future.

Co-authors

The 25 scholars most cited alongside Frédéric Maloisel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frédéric Maloisel Line = papers co-authored together Frédéric Maloisel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2010399
2 1997278
3 2006253
4 2008154
5 2006116
6 2010113
7 2005108
8 201099
9 199982
10 199978
11 200478
12 200175
13 200968
14 200167
15 201166
16 200660
17 200653
18 200753
19 200247
20
Review. Clinical pharmacokinetics of bortezomib.
200746

About Frédéric Maloisel

Frédéric Maloisel is a scholar working on Hematology, Genetics, Oncology, Genetics and Rheumatology, having authored 76 papers that have together received 3.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (22 papers), Chronic Myeloid Leukemia Treatments (20 papers), Blood disorders and treatments (15 papers), Lymphoma Diagnosis and Treatment (10 papers), Eosinophilic Disorders and Syndromes (10 papers), Neutropenia and Cancer Infections (8 papers), Multiple Myeloma Research and Treatments (7 papers) and Platelet Disorders and Treatments (6 papers). The work is most often cited by research in Hematology (1.5k citations), Genetics (562 citations), Oncology (759 citations), Pathology and Forensic Medicine (449 citations) and Rheumatology (366 citations). Frédéric Maloisel has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Emmanuel Andrès, Jacques Zimmer, Jean‐Luc Harousseau, Gérald Marit, Michel Attal, Denis Caillot, Mauricette Michallet, Jean Sibilia, Philippe Moreau and Thierry Façon. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, The American Journal of Medicine and European Journal of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact